Form 144: 1,762 NOW Shares Proposed Sale ($1.53M) via Fidelity
Form 144 notice shows a proposed sale of 1,762 shares of Common stock through Fidelity Brokerage Services (900 Salem St, Smithfield, RI) with an aggregate market value of $1,526,684.90 and approximately 208,000,000 shares outstanding.
Rhea-AI Filing Summary
Form 144 notice shows a proposed sale of 1,762 shares of Common stock through Fidelity Brokerage Services (900 Salem St, Smithfield, RI) with an aggregate market value of $1,526,684.90 and approximately 208,000,000 shares outstanding. The securities were acquired on 08/17/2025 via restricted stock vesting from the issuer and the payment is listed as compensation. The approximate date of sale is 08/18/2025. The filing also reports three prior sales by Gina Marie Mastantuono: 118 shares on 05/19/2025 (gross proceeds $121,569.50), 292 shares on 08/08/2025 ($256,489.88), and 84 shares on 08/13/2025 ($72,287.88). Several filer and issuer identification fields in the form are blank in the provided content.
Positive
- Transaction is small relative to float: 1,762 shares vs. 208,000,000 shares outstanding suggests minimal market impact
- Securities were acquired by restricted stock vesting, indicating they are compensation rather than opportunistic purchases
Negative
- Key filer and issuer identification fields are blank in the provided excerpt, limiting transparency
- Rapid disposition: acquisition on 08/17/2025 with proposed sale on 08/18/2025 may raise routine governance questions about holding period, though no rule violations are alleged in the form
Insights
TL;DR: Small executive/insider sale from recent restricted stock vesting; transaction sizes are immaterial relative to 208M shares outstanding.
The notice documents a proposed sale of 1,762 vested restricted shares with an indicated market value of $1.53M and an intended trade date of 08/18/2025 via Fidelity. Past reported disposals by Gina Marie Mastantuono total 494 shares across May and August 2025, generating roughly $450k in gross proceeds. The filing lacks issuer identification fields in the provided excerpt, limiting assessment of context such as insider role or ownership stake. From a market-impact perspective, 1,762 shares represent a de minimis portion of the reported 208,000,000 shares outstanding, so the direct supply effect is negligible.
TL;DR: Disclosure shows routine insider monetization of vested equity; form format is standard but some issuer/filer metadata is missing.
The table indicates acquisition by restricted stock vesting on 08/17/2025 and sale planned the following day, consistent with post-vesting disposition. The signature/filing contact fields in the supplied content are blank, and the issuer name is not shown in the excerpt; that missing metadata reduces traceability for shareholders. No material single-sale concentration or unusual trading plan details are present in the visible content.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does this Form 144 for NOW disclose about the proposed sale?
What prior sales by the same person are reported in the Form 144?
Which broker is handling the proposed sale?
Does the filing show the issuer name or filer CIK?
AI-generated analysis. How Rhea-AI works. Not financial advice.